← Leaderboards
Michael F Giordano
Weill Medical College Of Cornell Univ
$79,525
Attributed
$79,525
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$79,525 · 2
By mechanism
M01$79,525 · 2
Top collaborators
No co-investigators on record.
Most similar at Weill Medical College Of Cornell Univ
Same institution · by research overlap
- John P Moore$51,152,802
- Warren D. Johnson$21,766,636
- Kendall A Smith$14,630,665
- Rosemary Soave$325,825
- Min Lu$17,094,037
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchDrug Screening /EvaluationHuman SubjectHuman Therapy EvaluationEnzyme InhibitorsGanciclovirHiv InfectionsHuman Immunodeficiency Virus 1IntegraseOral AdministrationPharmacokineticsAids TherapyProdrugsAntiaids AgentClinical TrialsCytomegalovirus Retinitis
Grant awards (4)
PHASE I/II MULTIPLE DOSE STUDY OF ZINTEVIR IN HIV-1 PATIENTS$0
M01 · FY2001 · RR
COMPARISON OF SAFETY &EFFICACY OF RS 79070 &ORAL PRODRUG VS IV GANCICLOVIR$0
M01 · FY2001 · RR
PHASE I/II MULTIPLE DOSE STUDY OF ZINTEVIR IN HIV-1 PATIENTS$79,525
M01 · FY2000 · RR
COMPARISON OF SAFETY &EFFICACY OF RS 79070 &ORAL PRODRUG VS IV GANCICLOVIR$0
M01 · FY2000 · RR